Cargando…

Response to “Comments on the article ‘Value of urine-based lipoarabinomannan (LAM) antigen tests for diagnosing tuberculosis in children: systematic review and meta-analysis’”

Detalles Bibliográficos
Autores principales:	Seid, Getachew, Alemu, Ayinalem, Tsedalu, Tsegaye, Dagne, Biniyam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Correspondance
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505909/ https://www.ncbi.nlm.nih.gov/pubmed/37727822 http://dx.doi.org/10.1016/j.ijregi.2022.10.002

Ejemplares similares

Value of urine-based lipoarabinomannan (LAM) antigen tests for diagnosing tuberculosis in children: systematic review and meta-analysis
por: Seid, Getachew, et al.
Publicado: (2022)

Comments on the article ‘Value of urine-based lipoarabinomannan (LAM) antigen tests for diagnosing tuberculosis in children: systematic review and meta-analysis’
por: Keikha, Masoud
Publicado: (2022)

Microbiological diagnosis and mortality of tuberculosis meningitis: Systematic review and meta-analysis
por: Seid, Getachew, et al.
Publicado: (2023)

Tuberculosis in household contacts of tuberculosis patients in sub-Saharan African countries: A systematic review and meta-analysis
por: Seid, Getachew, et al.
Publicado: (2022)

Lipoarabinomannan Antigen Assay (TB-LAM) for Diagnosing Pulmonary Tuberculosis in Children with Severe Acute Malnutrition in Mozambique
por: Osório, Dulce-Vasco, et al.
Publicado: (2020)

Potential value of urine lateral-flow lipoarabinomannan (LAM) test for diagnosing tuberculosis among severely acute malnourished children
por: Schramm, Birgit, et al.
Publicado: (2021)

Correction: Potential value of urine lateral-flow lipoarabinomannan (LAM) test for diagnosing tuberculosis among severely acute malnourished children
por: Schramm, Birgit, et al.
Publicado: (2021)

Systematic, Point-of-Care Urine Lipoarabinomannan (Alere TB-LAM) Assay for Diagnosing Tuberculosis in Severely Immunocompromised HIV-Positive Ambulatory Patients
por: Huerga, Helena, et al.
Publicado: (2020)

Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review
por: Lawn, Stephen D
Publicado: (2012)

Sensitive electrochemiluminescence (ECL) immunoassays for detecting lipoarabinomannan (LAM) and ESAT-6 in urine and serum from tuberculosis patients
por: Broger, Tobias, et al.
Publicado: (2019)

Adherence to Isoniazid Preventive Therapy among Under-Five Children in Contact with Adult Bacteriologically Confirmed Pulmonary Tuberculosis Patients: A Mixed-Method Study
por: Seid, Getachew, et al.
Publicado: (2020)

Lateral Flow Urine Lipoarabinomannan Assay (LF-LAM) for Diagnosis of Active Tuberculosis in HIV-Infected Adults: a Prospective Cohort Study
por: Na Songkhla, Munjit, et al.
Publicado: (2017)

The Epidemiology of first and second-line drug-resistance Mycobacterium tuberculosis complex common species: Evidence from selected TB treatment initiating centers in Ethiopia
por: Dagne, Biniyam, et al.
Publicado: (2021)

Lipoarabinomannan antigenic epitope differences in tuberculosis disease subtypes
por: Magni, Ruben, et al.
Publicado: (2020)

Diagnosing tuberculosis in hospitalized HIV-infected individuals who cannot produce sputum: is urine lipoarabinomannan testing the answer?
por: Sabur, Natasha F., et al.
Publicado: (2017)

Detection of lipoarabinomannan (LAM) in urine is indicative of disseminated TB with renal involvement in patients living with HIV and advanced immunodeficiency: evidence and implications
por: Lawn, Stephen D., et al.
Publicado: (2016)

Improved Alere Determine Lipoarabinomannan Antigen Detection Test for the Diagnosis of Human and Bovine Tuberculosis by Manipulating Urine and Milk
por: García, Juan Ignacio, et al.
Publicado: (2019)

Lipoarabinomannan in urine during tuberculosis treatment: association with host and pathogen factors and mycobacteriuria
por: Wood, Robin, et al.
Publicado: (2012)

Urine lipoarabinomannan testing for diagnosis of pulmonary tuberculosis in children: a prospective study
por: Nicol, Mark P, et al.
Publicado: (2014)

Diagnostic accuracy of 3 urine lipoarabinomannan tuberculosis assays in HIV-negative outpatients
por: Broger, Tobias, et al.
Publicado: (2020)

Urine lipoarabinomannan for rapid tuberculosis diagnosis in HIV-infected adult outpatients in Khayelitsha
por: Sossen, Bianca, et al.
Publicado: (2021)

Preparation of monoclonal antibodies against mannosylated lipoarabinomannan (ManLAM), a surface antigen of BCG vaccine produced in Iran
por: Taghikhani, Mohammad, et al.
Publicado: (2016)

1496. Utility of Urinary Lipoarabinomannan (LAM) for Diagnosis of Tuberculosis in HIV-infected Hospitalized Patients – A Prospective Observational Study.
por: Kumar, Deepak, et al.
Publicado: (2023)

Detection of lipoarabinomannan (LAM) in urine is an independent predictor of mortality risk in patients receiving treatment for HIV-associated tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis
por: Gupta-Wright, Ankur, et al.
Publicado: (2016)

The diagnostic accuracy of pericardial and urinary lipoarabinomannan (LAM) assays in patients with suspected tuberculous pericarditis
por: Pandie, Shaheen, et al.
Publicado: (2016)

Does Xpert® MTB/RIF assay give rifampicin resistance results without identified mutation? Review of cases from Addis Ababa, Ethiopia
por: Alemu, Ayinalem, et al.
Publicado: (2020)

Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV‐positive adults
por: Shah, Maunank, et al.
Publicado: (2016)

Urine lipoarabinomannan glycan in HIV-negative patients with pulmonary tuberculosis correlates with disease severity
por: Paris, Luisa, et al.
Publicado: (2017)

Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV
por: Bjerrum, Stephanie, et al.
Publicado: (2019)

Biomarkers for tuberculosis: the case for lipoarabinomannan
por: Correia-Neves, Margarida, et al.
Publicado: (2019)

Effect of sputum quality and role of Xpert(®) MTB/ RIF assay for detection of smear-negative pulmonary tuberculosis in same-day diagnosis strategy in Addis Ababa, Ethiopia
por: Sinshaw, Waganeh, et al.
Publicado: (2022)

Diagnostic Accuracy of Urine Lipoarabinomannan Testing in Early Morning Urine versus Spot Urine for Diagnosis of Tuberculosis among People with HIV
por: Bjerrum, Stephanie, et al.
Publicado: (2022)

A systematic review of utility of urine lipoarabinomannan in detecting tuberculosis among HIV-positive tuberculosis suspects
por: Chatla, Chakrapani, et al.
Publicado: (2021)

Author Correction: Lipoarabinomannan antigenic epitope differences in tuberculosis disease subtypes
por: Magni, Ruben, et al.
Publicado: (2021)

Prognostic Value of a Quantitative Analysis of Lipoarabinomannan in Urine from Patients with HIV-Associated Tuberculosis
por: Kerkhoff, Andrew D., et al.
Publicado: (2014)

The Diagnostic Accuracy of Urine Lipoarabinomannan Test for Tuberculosis Screening in a South African Correctional Facility
por: Hanifa, Yasmeen, et al.
Publicado: (2015)

Comment on the Article: Outcome of Sclerokeratoplasty in Devastating Sclerocorneal Infections
por: Srirampur, Arjun
Publicado: (2020)

Isolation and purification of lipoarabinomannan from urine of adults with active TB
por: Cantera, J. L., et al.
Publicado: (2023)

Surveillance of drug resistance tuberculosis based on reference laboratory data in Ethiopia
por: Diriba, Getu, et al.
Publicado: (2019)

Rapid urine lipoarabinomannan assay as a clinic-based screening test for active tuberculosis at HIV diagnosis
por: Drain, Paul K., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_f2qvppp87c27q4h8eabebshjjc